HOLLY BAILEY: Open Payments
NPI 1518518174 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,714 in 220 payments from 19 companies in 2025. Trend: 2023 $2,786 · 2024 $4,199 · 2025 $4,714
Food & beverage: $4,618Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 64 | $1,233 |
| ABBVIE INC. | 38 | $857 |
| Madrigal Pharmaceuticals | 11 | $524 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $481 |
| PFIZER INC. | 20 | $396 |
| QOL Medical, LLC | 9 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $207 |
| Phathom Pharmaceuticals, Inc. | 7 | $156 |
| Ardelyx, Inc. | 4 | $112 |
| GENZYME CORPORATION | 3 | $99 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, RINVOQ, VELSIPITY, Sucraid, SKYRIZI, LINZESS.
Industry payments across NY — which companies pay providers there.
